Experimental and Molecular Pathology

Papers
(The H4-Index of Experimental and Molecular Pathology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway140
miRNA profile in ovarian cancer90
Long non-coding RNA signature in gastric cancer56
LEPR hypomethylation is significantly associated with gastric cancer in males51
Neuro-protective roles of long non-coding RNA MALAT1 in Alzheimer's disease with the involvement of the microRNA-30b/CNR1 network and the following PI3K/AKT activation49
Targeting miR-10a-5p/IL-6R axis for reducing IL-6-induced cartilage cell ferroptosis47
Non-coding RNA profile in lung cancer41
Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection40
LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes35
Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway33
The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker33
LncRNA GAS5 suppresses inflammatory responses and apoptosis of alveolar epithelial cells by targeting miR-429/DUSP130
MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH129
MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy29
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions28
RETRACTED: Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging27
miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets26
LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin26
The alterations of mitochondrial DNA in coronary heart disease26
MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway26
The critical roles of lncRNAs in the pathogenesis of melanoma24
MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO324
Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma24
Expression analysis of vimentin and the related lncRNA network in breast cancer23
LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis23
0.03489089012146